Literature DB >> 2738917

Human D-Phe-Pro-Arg-CH2-alpha-thrombin crystallization and diffraction data.

E Skrzypczak-Jankun1, T J Rydel, A Tulinsky, J W Fenton, K G Mann.   

Abstract

Human alpha-thrombin, inhibited with the high-affinity irreversible inhibitor D-Phe-Pro-Arg-chloromethylketone, has been crystallized from polyethylene glycol 8000 solutions buffered with 0.1 M-sodium phosphate. The crystals are: orthorhombic, a = 67.9(1) A, b = 87.9(1) A, c = 61.0(1) A, space group P2(1)2(1)2(1) with four molecules per unit cell. This gives a protein fraction of 58% consistent with the excellent X-ray diffraction quality of the crystals. A mercury heavy-atom derivative is being prepared from a thioester analogue of D-Phe-Pro-Arg-CH2-alpha-thrombin in anticipation of a complete crystallographic structure determination.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738917     DOI: 10.1016/0022-2836(89)90582-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  3 in total

1.  Crystallographic determination of the structures of human alpha-thrombin complexed with BMS-186282 and BMS-189090.

Authors:  M F Malley; L Tabernero; C Y Chang; S L Ohringer; D G Roberts; J Das; J S Sack
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

2.  The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.

Authors:  J Vijayalakshmi; K P Padmanabhan; K G Mann; A Tulinsky
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

3.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.